Consequently, the potential uPAR modulator proposed by this study could be a new class of anti-cancer agents for effectively treating cancers, since how these compounds change cancer hallmarks, such as via sustaining proliferative signaling, resisting cell death, inducing/accessing vasculature and activating invasion and metastasis, etc., is much clearer now. The gene discussed is PLAUR; the disease is cancer.